XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Note 13 - Segment Information
 9 Months Ended
Sep. 28, 2024
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

13.    Segment Information

 

The Company follows ASC 280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements included in its Annual Report on Form 10-K for the year ended December 30, 2023).

 

Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:

 

Thirteen Weeks Ended

September 28, 2024

 

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 

Revenue

 $26,554  $24,167  $9,644  $-  $60,365 

Cost of services

  18,271   18,273   5,980   -   42,524 

Gross profit

  8,283   5,894   3,664   -   17,841 

Selling, general and administrative

  6,510   4,294   2,214   -   13,018 

Depreciation and amortization of

property and equipment

  139   200   54   -   393 

Amortization of acquired

intangible assets

  -   -   45   -   45 

Operating income

 $1,634  $1,400  $1,351  $-  $4,385 

Total assets as of September 28, 2024

 $40,525  $52,321  $21,681  $11,018  $125,545 

Property and equipment acquired

 $68  $378  $-  $76  $522 

 

 

 

Thirteen Weeks Ended

September 30, 2023

 

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 

Revenue

 $24,895  $22,452  $10,702  $-  $58,049 

Cost of services

  17,438   16,846   6,484   -   40,768 

Gross profit

  7,457   5,606   4,218   -   17,281 

Selling, general and administrative

  5,977   4,327   2,358   -   12,662 

Depreciation and amortization of

property and equipment

  88   122   33   -   243 

Amortization of acquired

intangible assets

  -   -   45   -   45 

Operating income

 $1,392  $1,157  $1,782  $-  $4,331 

Total assets as of September 30, 2023

 $32,272  $45,949  $17,662  $5,331  $101,214 

Property and equipment acquired

 $62  $162  $69  $22  $315 

 

 

 

 

Thirty-Nine Weeks Ended

September 28, 2024

 

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 

Revenue

 $101,668  $70,180  $29,620  $-  $201,468 

Cost of services

  71,672   52,818   18,769   -   143,259 

Gross profit

  29,996   17,362   10,851   -   58,209 

Selling, general and administrative

  21,252   12,515   6,995   -   40,762 

Depreciation and amortization of

property and equipment

  372   505   135   -   1,012 

Amortization of acquired

intangible assets

  -   -   136   -   136 

Costs associated with potential stock

issuance

  -   -   -   259   259 

Operating income (loss)

 $8,372  $4,342  $3,585  $(259) $16,040 

Total assets as of September 28, 2024

 $40,525  $52,321  $21,681  $11,018  $125,545 

Property and equipment acquired

  235  $622  $20  $712  $1,589 

 

 

 

Thirty-Nine Weeks Ended

September 30, 2023

 

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 

Revenue

 $99,553  $61,956  $30,700  $-  $192,209 

Cost of services

  70,623   47,482   19,039   -   137,144 

Gross profit

  28,930   14,474   11,661   -   55,065 

Selling, general and administrative

  19,211   12,626   6,945   -   38,782 

Depreciation and amortization of

property and equipment

  281   370   105   -   756 

Amortization of acquired

intangible assets

  -   -   136   -   136 

Gain on sale of assets

  -   (395)  -   -   (395)

Operating income

 $9,438  $1,873  $4,475  $-  $15,786 

Total assets as of September 30, 2023

 $32,272  $45,949  $17,662  $5,331  $101,214 

Property and equipment acquired

 $109  $640  $88  $38  $875 

 

 

 

The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Europe. Revenue by geographic area for the thirteen and thirty-nine weeks ended September 28, 2024 and September 30, 2023 was as follows:

 

  

Thirteen Weeks Ended

  

Thirty-Nine Weeks Ended

 
  

September 28, 2024

  

September 30, 2023

  

September 28, 2024

  

September 30, 2023

 

Revenue

                

United States

 $55,322  $53,679  $185,742  $179,800 

Canada

  1,895   1,647   4,982   5,060 

Puerto Rico

  1,568   1,643   5,588   4,745 

Europe

  1,580   1,080   5,156   2,604 
  $60,365  $58,049  $201,468  $192,209 

 

Total assets by geographic area as of the reported periods were as follows:

 

  

September 28, 2024

  

December 30,

2023

 

Total assets

        

United States

 $114,067  $110,781 

Canada

  1,924   1,880 

Puerto Rico

  3,127   3,476 

Europe

  6,427   4,347 
  $125,545  $120,484